Advances in the treatment of multiple myeloma: a nursing perspective.
Barrick
Mechelle
M
Greater Baltimore Medical Center, Maryland, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy*; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D017410:Practice Guidelines as Topic; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D011788:Quality of Life / Q000523:psychology; D033581:Stem Cell Transplantation; D015996:Survival Rate; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011480:Protease Inhibitors; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide